Sacubitril And Valsartan Tablet, Film Coated
Product Images NDC 70748-195

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sacubitril And Valsartan (NDC 70748-195). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (781df5f7 56d9 43de 805e F9ce9f931690 01)

Chemical structure diagram of sacubitril, part of the combination drug sacubitril and valsartan, depicted with labeled atoms and bonds.*

FDA Label Image

Image (781df5f7 56d9 43de 805e F9ce9f931690 02)

Chemical structure of sacubitril, showing the arrangement of atoms and bonds including a triazole ring and a sodium salt form with two sodium ions (2Na+).*

FDA Label Image

Image (781df5f7 56d9 43de 805e F9ce9f931690 03)

A chart showing geometric mean ratios and 90% confidence intervals for various coadministered drugs relative to a reference. The chart compares AUC and Cmax values for drugs including Furosemide, Warfarin, Digoxin, Carvedilol, Levonorgestrel, Ethinyl estradiol, Amlodipine, HCTZ, Metformin, Atorvastatin, and Sildenafil, with data points indicated by circles and squares along a horizontal axis labeled 'Change relative to reference.'*

FDA Label Image

Image (781df5f7 56d9 43de 805e F9ce9f931690 04)

A comparative forest plot chart showing the geometric mean ratio and 90% confidence intervals for AUC and Cmax changes relative to reference across various population subgroups. Subgroups include renal impairment levels, hepatic impairment, age groups, sex, and ethnicities, with data points for LBQ657 and Valsartan.*

FDA Label Image

Image (781df5f7 56d9 43de 805e F9ce9f931690 05)

Three line graphs comparing the time to first occurrence of cardiovascular death or heart failure hospitalizations in the PARADIGM-HF study for sacubitril and valsartan tablets versus enalapril. Each graph shows cumulative incidence over time with hazard ratios indicating risk reduction for sacubitril and valsartan compared to enalapril. Number of patients at risk at various time points is listed below each graph.*

FDA Label Image

Image (781df5f7 56d9 43de 805e F9ce9f931690 06)

A forest plot comparing the hazard ratios with 95% confidence intervals between sacubitril and valsartan tablets and enalapril across various subgroups including age, gender, weight, race, region, NYHA class, estimated GFR, diabetes status, systolic blood pressure, ejection fraction, atrial fibrillation, NT-proBNP, hypertension, prior use of ACE inhibitors or ARBs, prior use of aldosterone antagonists, prior heart failure hospitalization, time since diagnosis, cause of heart failure, and ICD usage. Each subgroup lists sample sizes and event rates for both drugs with a graphical summary of comparative risk.*

FDA Label Image

24 26 60 (781df5f7 56d9 43de 805e F9ce9f931690 07)

Label for sacubitril and valsartan film-coated tablets 24 mg/26 mg, manufactured for Lupin Pharmaceuticals, Inc. The label indicates 60 tablets per package with a national drug code (NDC) 70748-195-07. It includes storage instructions for controlled room temperature and mentions manufacturer details as AET Laboratories Pvt. Ltd., India.*

FDA Label Image

49 51 60 (781df5f7 56d9 43de 805e F9ce9f931690 08)

Label for Sacubitril and Valsartan Tablets 49 mg/51 mg film-coated tablets. The carton indicates Rx only, contains 60 tablets, and is manufactured for Lupin Pharmaceuticals, Inc. The label includes storage instructions and manufacturing details for AET Laboratories Pvt. Ltd. in India. NDC 70748-196-07.*

FDA Label Image

97-103-60s (781df5f7 56d9 43de 805e F9ce9f931690 09)

Packaging label for Sacubitril and Valsartan Tablets, 97 mg/103 mg strength, film-coated oral tablets. The label states the product is prescription only (Rx only) and comes in a 60-tablet count. Manufactured for Lupin Pharmaceuticals, Inc. with production by AET Laboratories Pvt. Ltd in India. The label includes storage instructions, barcode, and batch information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.